The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...

Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...

List prices for drugs often differ from what ... Both Humalog and Insulin Lispro Injection are fast-acting insulins, they are used to control high blood sugar in adults and children with diabetes ...

Biosimilars marketed in the US typically have list prices 15% to 35% lower than ... if needed – at mealtimes for example – with fast-acting insulins. The cost of insulin products has become ...

Mariposa California's original daily updated online newspaper is the premier site for news and information on Yosemite, ...

Merilog, a rapid-acting human insulin analog, is the first rapid-acting insulin biosimilar product approved by the FDA. As a rapid-acting insulin, Merilog helps to lower mealtime blood sugar ...

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.